Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Most Read

  1. Pat-INFORMED: the solution to drug patent procurement issues?
  2. Mylan recalls all lots of blood pressure drugs containing valsartan
  3. UCB to invest £1bn in the UK Life Sciences Sector Deal
  4. Gut health: are probiotics as effective as consumers believe?
  5. Four new Pfizer brands will help make up for looming Lyrica patent expiry

Latest Content

November’s top stories

Sobi has signed agreements to acquire the rights to AstraZeneca’s Synagis medicine in the US for an upfront payment of $1.5bn, and Takeda Pharmaceutical has received a conditional approval from the EC for the $62bn proposed acquisition of Irish biopharmaceutical company Shire. wraps up key headlines from November 2018.

Pat-INFORMED: the solution to drug patent procurement issues?

Many countries do not have the equivalent to the US’s Orange book, meaning that health officials are wasting time establishing whether patents have been taken out on medicines. Leading biopharmaceutical companies have worked together to develop Pat-INFORMED, a new global platform that could allow government procurement agencies to access information on thousands of individual patents anywhere in the world.

Latest News

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Go Top